F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: A Review

Journal of Clinical Biochemistry and Nutrition - Japan
doi 10.3164/jcbn.08-266
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Society for Free Radical Research Japan

Related search

Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Biomarkers in Type 2 Diabetes

International Journal of Diabetes & Metabolic Disorders
2018English

Circulating microRNAs as Novel Biomarkers for Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2013English

Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus

Baylor University Medical Center Proceedings
Medicine
2006English

Circulating microRNAs as Biomarkers for Type 1 Diabetes Mellitus

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Type 2 Diabetes Prevention: A Review

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

MicroRNAs in Type 2 Diabetes Mellitus: Important for the Pathogenesis but Uncertain as Biomarkers

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes

PLoS ONE
Multidisciplinary
2010English

Nutritional Supplementation for Type 2 Diabetes: A Systematic Review

Ophthalmic and Physiological Optics
OphthalmologySensory SystemsOptometry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy